Kintz Samuel bought ELVN
January 25, 2024 · Form 4 insider transaction
Kintz Samuel bought 12,000 shares of Enliven Therapeutics, Inc. at $1.12 per share, a transaction worth $13.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
$1.12
Total value
$13.4K
InsiderKintz Samuel
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 25, 2024
Filing dateJanuary 29, 2024
Shares owned after12,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.